Question 11a. Industry and timelineThe industry in which Pfizer Inc operated is pharmaceutical industry in the global region. Thetype of business is B2C. The analysis period is from 1996 – 2006. 1a. PESTEL analysisFactorsExplanation (with supporting case evidence) OpportunityThreatPoliticalFDA imposed severe restrictions on what could claim as the drug’s benefit. (pg 3-4, para 6).It is a threat because the players have to work hard to get the approval in order to sell its drug.It is an opportunity because only approved drug will get to see its potential market and relevant patient population.U.S granted patent protection of 17-20 years to new chemicalentities (pg 5, para 1).It is an opportunity as the patent drug can only be manufactured and market by the company that developed.It is a threat because once the patent expired; other players may manufacture and sold the drug. Differential pricing strategy due to government intervention. (pg 7 para 1). It is a threat because cheaper drugs may be bought at one country like Canada and resold for a premium in another.Question 11